Evidence for role of cyclic AMP as second messenger of arrhythmogenic effects of beta-stimulation.
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000503:physiopathology*; D003994:Bucladesine / Q000494:pharmacology; D003327:Coronary Disease / Q000503:physiopathology; D000242:Cyclic AMP / Q000494:pharmacology / Q000502:physiology*; D004195:Disease Models, Animal; D006321:Heart / Q000187:drug effects / Q000502:physiology; D006352:Heart Ventricles / Q000503:physiopathology; D009200:Myocardial Contraction / Q000187:drug effects; D011188:Potassium / Q000494:pharmacology; D011941:Receptors, Adrenergic / Q000502:physiology*; D011943:Receptors, Adrenergic, beta / Q000502:physiology*; D013552:Swine; D013806:Theophylline / Q000494:pharmacology
D011941:Receptors, Adrenergic; D011943:Receptors, Adrenergic, beta; D003994:Bucladesine; D013806:Theophylline; D000242:Cyclic AMP; D011188:Potassium